Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Relmada Therapeutics, Inc. Common Stock (RLMD)

Pharmaceutical Preparations

https://www.relmada.com

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

2222 PONCE DE LEON BLVD. 3RD FLOOR
CORAL GABLES, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/03/2014

Market Cap

72,719,822

Shares Outstanding

30,100,000

Weighted SO

30,099,203

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.4970

Last Div

0.0000

Range

1.88-7.223

Chg

-0.1600

Avg Vol

116038

Mkt Cap

72719822

Exch

NASDAQ

Country

US

Phone

786 629 1376

DCF Diff

2.3941

DCF

0.1359

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.7788

P/FV

1.1826

Div Yield %

0.0000

P/E

-0.8381

PEG

-0.0220

Payout

0.0000

Current Ratio

7.4422

Quick Ratio

7.4422

Cash Ratio

0.2188

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.2805

ROA

-1.2215

ROE

-1.0858

ROCE

-1.4852

NI/EBT

1.0000

EBT/EBIT

0.9500

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.1551

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.5967

FCF/Share

-1.5967

Cash/Share

2.3344

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.1826

P/B

1.1826

P/S

0.0000

P/E

-0.8381

P/FCF

-1.5093

P/OCF

-1.5093

P/CF

-1.5093

PEG

-0.0220

P/S

0.0000

EV Multiple

-0.7788

P/FV

1.1826

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation